# Design Therapeutics, Inc.: Form 8-K, filed Apr 1, 2026

- Company: [Design Therapeutics, Inc.](/companies/dsgn.md) (CIK 1807120)
- Form: 8-K
- Filed: 2026-04-01
- Accepted by EDGAR: Apr 1, 2026, 16:03 ET
- Period: 2026-03-31
- Accession: 0001193125-26-137861
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1807120/000119312526137861/dsgn-20260331.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1807120/000119312526137861/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1807120/000119312526137861/dsgn-20260331.htm

Filed Apr 1, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-137861. Last ingested by Listed: Nov 14, 2026, 10:50 ET. No prices; not investment advice.
